BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Chubb
Moodys
Merck
Federal Trade Commission
Dow
Deloitte
US Army
Fish and Richardson
Cantor Fitzgerald

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,223,510

« Back to Dashboard

Which drugs does patent 5,223,510 protect, and when does it expire?

Patent 5,223,510 protects MULTAQ and is included in one NDA.

This patent has forty patent family members in thirty-two countries.
Summary for Patent: 5,223,510
Title: Alkylaminoalkyl derivatives of benzofuran, benzothiophene, indole and indolizine, process for their preparation and compositions containing them
Abstract:The subject of the invention is benzofuran, benzothiophene, indole or indolizine compounds of general formula: ##STR1## in which: Het represents one of the groups: ##STR2## in which T,T' and T"represent particularly a group: ##STR3## R and R.sub.a, identical or different, represent X represent --O-- or --S-- Y represents a radical ##STR4## These compounds are useful as medecines particularly for the treatment of pathological syndroms of the cardio-vascular system.
Inventor(s): Gubin; Jean (Brussels, BE), Chatelain; Pierre (Brussels, BE), Lucchetti; Jean (Chastre, BE), Rosseels; Gilbert (Wemmel, BE), Inion; Henri (Wemmel, BE)
Assignee: Sanofi (Paris, FR)
Application Number:07/736,580
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Drugs Protected by US Patent 5,223,510

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Sanofi Aventis Us MULTAQ dronedarone hydrochloride TABLET;ORAL 022425-001 Jul 1, 2009 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y REDUCTION OF THE RISK OF CARDIOVASCULAR HOSPITALIZATION ➤ Subscribe
Sanofi Aventis Us MULTAQ dronedarone hydrochloride TABLET;ORAL 022425-001 Jul 1, 2009 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y REDUCTION OF THE RISK OF HOSPITALIZATION FOR ATRIAL FIBRILLATION ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,223,510

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France90 10036Aug 06, 1990

International Patents Family Members for US Patent 5,223,510

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2047773 ➤ Subscribe
Czechoslovakia 9102427 ➤ Subscribe
Czech Republic 288527 ➤ Subscribe
Germany 69123304 ➤ Subscribe
Denmark 0471609 ➤ Subscribe
European Patent Office 0471609 ➤ Subscribe
Spain 2096639 ➤ Subscribe
Finland 913704 ➤ Subscribe
Finland 114914 ➤ Subscribe
France 2665444 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Citi
Johnson and Johnson
Boehringer Ingelheim
Daiichi Sankyo
McKinsey
Farmers Insurance
Queensland Health
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot